Gluten-Drug Rule Petitioner Claims Time Has Expired For FDA Decision
This article was originally published in The Tan Sheet
Executive Summary
A lawsuit seeks to declare FDA’s failure to act on a 2008 citizen petition requesting a ban of wheat gluten in OTCs and Rx drugs in violation of the Administrative Procedure Act. The complaint alleges the agency’s delay is unreasonable and asks the court to order FDA to make a decision within 30 days.
You may also be interested in...
In Brief
CHPA stands up for gluten in OTCs; Sen. Durbin targets energy drink supplement labeling; CDC report delves into U.S. nutritional data; P&G files tooth whitening patent suit against Be Well Health Marketing; more news In Brief.
In Brief
FDA proposes amending ANDA-blocking petition reg; Sara Lee snaps up Tea Forté; testing by FDA, CDC find no bacteria in Enfamil formula powder; USP offers draft probiotics standards; more news In Brief.
FDA Proposes Rule On Gluten-Free Labeling
Food products with "gluten-free" claims will be misbranded if they do not meet the conditions of a proposed rule FDA published in the Jan. 23 Federal Register